Claims
- 1. A chimeric gene comprising:
(a) a DNA molecule isolated from a plant, which in its native state encodes a polypeptide that comprises:
(i) a plastid transit peptide, and (ii) a mature enzyme that is natively targeted to a plastid of said plant by the plastid transit peptide, wherein said DNA molecule is modified such that it does not encode a functional plastid transit peptide; and (b) a promoter capable of expressing said DNA molecule in a plastid, wherein said promoter is operatively linked to said DNA molecule.
- 2. A chimeric gene according to claim 1, wherein said enzyme is naturally inhibited by a herbicidal compound.
- 3. A chimeric gene according to claim 2, wherein said enzyme has at least one amino acid modification compared to a corresponding naturally occurring enzyme, wherein said at least one amino acid modification confers resistance to an inhibitor of the naturally occurring enzyme.
- 4. A chimeric gene according to claim 1, wherein said enzyme has protoporphyrinogen oxidase (protox) activity.
- 5. A chimeric gene according to claim 4, wherein said enzyme has at least one amino acid modification compared to a naturally occurring protox enzyme, wherein said at least one amino acid modification confers resistance to an inhibitor of the naturally occurring protox enzyme.
- 6. A chimeric gene according to claim 5, wherein said at least one amino acid modification comprises an amino acid substitution occurring at a position corresponding to position 240, 245, 246, 388, 390, 451, 455, 500, or 536 of the comparitive alignment shown in Table 1.
- 7. A chimeric gene according to claim 6, wherein said at least one amino acid modification further comprises an additional amino acid substitution occuring at a position corresponding to position 143, 274, 330, 450, or 523 of the comparitive alignment shown in Table 1.
- 8. A chimeric gene according to claim 5, wherein said DNA molecule is isolated from Arabidopsis thaliana.
- 9. A chimeric gene according to claim 8, wherein said amino acid substitution occurs at a position corresponding to position 215, 220, 221, 363, 365, 426, 430, 475, or 511 of SEQ ID NO:2.
- 10. A chimeric gene according to claim 9, wherein a cysteine occurring at the position corresponding to position 215 of SEQ ID NO:2 is replaced with phenylalanine, leucine, or lysine.
- 11. A chimeric gene according to claim 9, wherein an alanine occurring at the position corresponding to position 220 of SEQ ID NO:2 is replaced with valine, threonine, leucine, cysteine, or isoleucine.
- 12. A chimeric gene according to claim 9, wherein a glycine occurring at the position corresponding to position 221 of SEQ ID NO:2 is replaced with serine or leucine.
- 13. A chimeric gene according to claim 9, wherein a proline occurring at the position corresponding to position 363 of SEQ ID NO:2 is replaced with serine or histidine.
- 14. A chimeric gene according to claim 9, wherein a valine occurring at the position corresponding to position 365 of SEQ ID NO:2 is replaced with leucine.
- 15. A chimeric gene according to claim 9, wherein a tyrosine occurring at the position corresponding to position 426 of SEQ ID NO:2 is replaced with cysteine, isoleucine, leucine, threonine, methionine, valine, alanine, or arginine.
- 16. A chimeric gene according to claim 9, wherein a serine occurring at the position corresponding to position 430 of SEQ ID NO:2 is replaced with proline.
- 17. A chimeric gene according to claim 9, wherein a isoleucine occurring at the position corresponding to position 475 of SEQ ID NO:2 is replaced with threonine, histidine, glycine, or asparagine.
- 18. A chimeric gene according to claim 9, wherein a valine occurring at the position corresponding to position 511 of SEQ ID NO:2 is replaced with alanine.
- 19. A chimeric gene according to claim 9, wherein said at least one amino acid modification further comprises an additional amino acid substitution occuring at a position corresponding to position 118, 249, 305, 425, or 498 of SEQ ID NO:2.
- 20. A chimeric gene according to claim 9, wherein said at least one amino acid modification comprises an amino acid substitution occurring at a position corresponding to position 220 or 426 of SEQ ID NO:2 and an additional amino acid substitution occurring at a position corresponding to position 118, 249, 305, 425, or 498 of SEQ ID NO:2.
- 21. A chimeric gene according to claim 20, wherein a proline occurring at the position corresponding to position 118 of SEQ ID NO:2 is replaced with leucine.
- 22. A chimeric gene according to claim 20, wherein a threonine occurring at the position corresponding to position 249 of SEQ ID NO:2 is replaced with isoleucine or alanine.
- 23. A chimeric gene according to claim 20, wherein a serine occurring at the position corresponding to position 305 of SEQ ID NO:2 is replaced with leucine.
- 24. A chimeric gene according to claim 20, wherein an asparagine occurring at the position corresponding to position 425 of SEQ ID NO:2 is replaced with serine.
- 25. A chimeric gene according to claim 207, wherein a tyrosine occurring at the position corresponding to position 498 of SEQ ID NO:2 is replaced with cysteine.
- 26. A chimeric gene according to claim 1, wherein said promoter is isolated from the 5′ flanking region upstream of the coding sequence of a plastid clpP gene.
- 27. A chimeric gene according to claim 26, wherein said plastid clpP gene is from tobacco.
- 28. A chimeric gene according to claim 26, wherein said plastid clpP gene is from Arabidopsis thaliana.
- 29. A chimeric gene according to claim 1, wherein said promoter is isolated from the 5′ flanking region upstream of the coding sequence of a plastid 16S ribosomal RNA operon.
- 30. A chimeric gene according to claim 1, wherein said DNA molecule is modified in that at least a portion of the native plastid transit peptide coding sequence is absent from said DNA molecule.
- 31. A chimeric gene according to claim 30, wherein said DNA molecule is modified in that all of the native plastid transit peptide coding sequence is absent from said DNA molecule.
- 32. A chimeric gene according to claim 1, wherein said DNA molecule is modified in that one or more nucleotides of the native plastid transit peptide coding sequence are mutated, thereby rendering an encoded plastid transit peptide nonfunctional.
- 33. A plastid transformation vector comprising a chimeric gene according to claim 1.
- 34. A plastid comprising a plastid transformation vector according to claim 33.
- 35. A plant, plant tissue, or plant cell, including the progeny thereof, comprising a plastid according to claim 34.
- 36. A plastid transformation vector comprising a chimeric gene according to claim 3.
- 37. A plastid comprising a plastid transformation vector according to claim 36.
- 38. A plant, plant tissue, or plant cell, including the progeny thereof, comprising a plastid according to claim 37.
- 39. A plastid transformation vector comprising a chimeric gene according to claim 5.
- 40. A plastid comprising a plastid transformation vector according to claim 39.
- 41. A plant, plant tissue, or plant cell, including the progeny thereof, comprising a plastid according to claim 40.
- 42. A method for controlling the growth of undesired vegetation, which comprises applying to a population of a plant according to claim 35 an effective amount of an inhibitor of the enzyme.
- 43. A method for controlling the growth of undesired vegetation, which comprises applying to a population of a plant according to claim 38 an effective amount of an inhibitor of the enzyme.
- 44. A method for controlling the growth of undesired vegetation, which comprises applying to a population of a plant according to claim 41 an effective amount of a protox inhibitor.
- 45. A method of producing a plant that is tolerant to a herbicidal compound in an amount that naturally inhibits plant growth, comprising the steps of:
(a) introducing a chimeric gene according to claim 2 into the plastome of a plant; and (b) expressing said DNA molecule in the plastids of said plant.
- 46. A method of producing a plant that is tolerant to a herbicidal compound in an amount that naturally inhibits plant growth, comprising the steps of:
(a) introducing a chimeric gene according to claim 3 into the plastome of a plant; and (b) expressing said DNA molecule in the plastids of said plant.
- 47. A method of producing a plant that is tolerant to a herbicidal compound in an amount that naturally inhibits plant growth, comprising the steps of:
(a) introducing a chimeric gene according to claim 5 into the plastome of a plant; and (b) expressing said DNA molecule in the plastids of said plant.
- 48. A method for selecting a transplastomic plant cell, comprising the steps of:
(a) introducing a chimeric gene according to claim 1 into the plastome of a plant cell; (b) expressing the enzyme encoded by said DNA molecule in the plastids of said plant cell; and (c) selecting a cell that is resistant to a herbicidal compound that naturally inhibits the activity of the enzyme encoded by said DNA molecule, whereby the resistant cell comprises transformed plastids.
- 49. A method for selecting a transplastomic plant cell, comprising the steps of:
(a) introducing a chimeric gene according to claim 3 into the plastome of a plant cell; (b) expressing the enzyme encoded by said DNA molecule in the plastids of said plant cell; and (c) selecting a cell that is resistant to a herbicidal compound that naturally inhibits the activity of the enzyme encoded by said DNA molecule, whereby the resistant cell comprises transformed plastids.
- 50. A method for selecting a transplastomic plant cell, comprising the steps of:
(a) introducing a chimeric gene according to claim 5 into the plastome of a plant cell; (b) expressing the enzyme encoded by said DNA molecule in the plastids of said plant cell; and (c) selecting a cell that is resistant to a herbicidal compound that naturally inhibits the activity of the enzyme encoded by said DNA molecule, whereby the resistant cell comprises transformed plastids.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation-in-part of U.S. application Ser. No. 09/050,603, filed Mar. 30, 1998, which is a continuation-in-part of U.S. application Ser. No. 08/808,931, filed Feb. 28, 1997, which itself claims the benefit of U.S. Provisional Application No. 60/012,705, filed Feb. 28, 1996, U.S. Provisional Application No. 60/013,612, filed Feb. 28, 1996, and U.S. Provisional Application No. 60/020,003, filed Jun. 21, 1996. This application is also a continuation-in-part of U.S. application Ser. No. 09/038,878, filed Mar. 11, 1998. All of the aforementioned applications are incorpororated herein by reference in their entireties.
Provisional Applications (4)
|
Number |
Date |
Country |
|
60012705 |
Feb 1996 |
US |
|
60013612 |
Feb 1996 |
US |
|
60020003 |
Jun 1996 |
US |
|
60126430 |
Mar 1998 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09059164 |
Apr 1998 |
US |
Child |
09730917 |
Dec 2000 |
US |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
09050603 |
Mar 1998 |
US |
Child |
09059164 |
Apr 1998 |
US |
Parent |
08808931 |
Feb 1997 |
US |
Child |
09050603 |
Mar 1998 |
US |